Biogen: Let’s Start All Over Again
October 25, 2017 at 12:24 PM EDT
Did yesterday's pullback create a buying opportunity? BMO Capital Markets analyst Ian Somaiya believes that worries surrounding the drug maker are quickly getting priced into the stock.